Myelodysplastic syndrome (MDS) arises from defective blood stem cells that progressively lose their normal functions.

Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional ...

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...